Drug Eluting Stent Market Size & Forecast Report, 2013 - 2024

The Drug Eluting Stent Market is projected to register a higher CAGR during the forecast period. The drug eluting stent market is highly driven by change in consumers’ lifestyles, heavy consumption of junk food, and prevalence of atherosclerosis in geriatric population. Adoption of minimally invasive techniques may augment the market demand for drug eluting stents.

Increase in geriatric population and shift from angioplasty to DES are likely to propel the market growth during the forecast period. Market challenges such as declining prices and side effects pertaining to the use of drug eluting stents might impede the market growth. Based on polymer coating, the drug eluting stents market comprises non-biodegradable polymer-based and biodegradable polymer based. Based on polymer free coatings, the drug eluting stent industry includes nanoporous surface, slotted tubular surface, micro porous surface and microstructures surface.

By application, the market segmentation includes coronary artery disease and peripheral artery disease. Geographical segmentation for drug eluting stent market includes North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America is a dominant market with greater revenue share. The market is driven by stringent norms and regulations along with favorable reimbursement coverage. Rise in incidences of artery diseases is expected to favor the market growth in the forecast period.

Asia-Pacific’s market is anticipated to register a higher market growth in the forecast period owing to rise in patients’ awareness pertaining to commercial availability of products, government funding and constant R&D. Improvements in healthcare infrastructure and increase in healthcare spending is likely to propel the market growth APAC sector.

The key players in the drug eluting stents industry include Abbott Laboratories, AlviMedica, Arterius, Biotronik SE Co & KG, Biosensors International Group Ltd, Boston Scientific Corporation, Cook Medical Inc, Elixir Medical Inc. Other vendors include Kyoto Medical Planning Co Ltd, Lepu Medical Technology Co Ltd, Micell Technologies Inc, Medtronic Plc, Eurocor GmbH, Opto Circuits, OrbusNeich Medical Company Ltd, QualiMed, Sino Medical Sciences Technology Inc, Sino Medical Sciences Technology Inc, and Stentys SA.

Market Segment:

Drug Eluting Stent Market, by Product, 2013 - 2024 (USD Million)
    • Polymer-based Coatings
    • Polymer-free Coatings

Drug Eluting Stent Market, by Application, 2013 - 2024 (USD Million)
    • Coronary Artery Disease
    • Peripheral Artery Disease

Drug Eluting Stent, by Region, 2013 - 2024 (USD Million)
    • North America
        • U.S. Drug Eluting Stents Market, by Product
        • U.S. Drug Eluting Stents Market, by Application
        • Canada Drug Eluting Stents Market, by Product
        • Canada Drug Eluting Stents Market, by Application
    • Europe
        • Germany Drug Eluting Stents Market, by Product
        • Germany Drug Eluting Stents Market, by Application
        • UK Drug Eluting Stents Market, by Product
        • UK Drug Eluting Stents Market, by Application
    • Asia Pacific
        • China Drug Eluting Stents Market, by Product
        • China Drug Eluting Stents Market, by Application
        • Japan Drug Eluting Stents Market, by Product
        • Japan Drug Eluting Stents Market, by Application
    • Latin America
        • Brazil Drug Eluting Stents Market, By Product
        • Brazil Drug Eluting Stents Market, By Application
        • Mexico Drug Eluting Stents Market, By Product
        • Mexico Drug Eluting Stents Market, By Application
    • MEA
        • South Africa Drug Eluting Stents Market, By Product
        • South Africa Drug Eluting Stents Market, By Application